sales are now falling with biosimilars)
They are not intended to represent clinical evidence in humans, and AOD-9604 has not been approved by the FDA, EMA, or any other regulatory authority for any indication
How Storage Impacts Reconstituted Peptides Lets connect the final dots
However, in the pivotal Phase IIb trial, it failed to demonstrate statistically significant weight loss compared to placebo at the primary endpoint, leading the developer (Metabolic Pharmaceuticals Ltd.) to terminate the commercial program
Peptides for Weight Loss Research Retatrutide vs Tirzepatide (For metabolic peptide comparisons) MOTS-c vs 5-Amino-1MQ (For cellular energy comparisons) FAQ Can you use BPC-157 and TB-500 together
In: Ohno S., Aoki K., Usui M., editors